Tafluprost is a potent FP receptor agonist; it can be used for the treatment of elevated intraocular pressure (IOP) in glaucoma. Tafluprost is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the DMF for Tafluprost is available for customer review upon request. The DMF has been filed with the US FDA and in Russia.